ArticleInternational journal of cancer2022

Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.

Yann-Alexandre Vano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.